Unraveling the paradoxical link between obesity and heart failure: the role of adipocytokines

References

• Hobbs FDR, Kenkre J, Roalfe AK, Davis RC, Hare R, Davies MK. Impact of heart failure and left ventricular systolic dysfunction on quality of life. Eur. Heart J.23, 1867–1876 (2002).
   PubMed Web of Science ®Google Scholar
• Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation88, 107–115 (1993).
   PubMed Web of Science ®Google Scholar
• McMurray JJ, Stewart S. Epidemiology, aetiology and prognosis of heart failure. Heart83, 596–602 (2000).
   PubMed Web of Science ®Google Scholar
• Spencer F, Meyer T, Goldberg R J et al. Twenty year trends (1975–1995) in the incidence, in-hospital and long-term death rates associated with heart failure complicating acute myocardial infarction: a community-wide perspective. J. Am. Coll. Cardiol.34, 1378–1387 (1999).
   PubMedGoogle Scholar
• Nicod P, Gilpin E, Dittrich H et al. Influence on prognosis and morbidity of left ventricular ejection fraction with and without signs of left ventricular failure after acute myocardial infarction. Am. J. Cardiol.61, 1165–71 (1988).
   PubMedGoogle Scholar
• Emanuelsson H, Karlson W, Herlitz J. Characteristics and prognosis of patients with acute myocardial infarction in relation to occurrence of congestive heart failure. Eur. Heart J.15, 761–768 (1994).
   PubMedGoogle Scholar
• Opie LH. The metabolic vicious cycle in heart failure. Lancet364, 1733–1734 (2004).
   PubMedGoogle Scholar
• Kannel WB, LeBauer EJ, Dawber TR, McNamara PM. Relation of body weight to development of coronary heart disease. The Framingham Study. Circulation35, 734–744 (1967).
   PubMed Web of Science ®Google Scholar
• Alpert MA. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am. J. Med. Sci.321, 225–236 (2001).
   PubMed Web of Science ®Google Scholar
• Kenchaiah S, Evans JC, Levy D et al. Obesity and the risk of heart failure. N. Engl. J. Med.347(5), 305–13 2002.
   PubMed Web of Science ®Google Scholar
• Stamler J. Epidemiologic findings on body mass and blood pressure in adults. Ann. Epidemiol.1, 347–362 (1991).
   PubMedGoogle Scholar
• Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham Study. Diabetes Care2, 120–126 (1979).
   PubMedGoogle Scholar
• Considine RV, Subha MK, Heiman ML et al. Serum immunoreactive leptin concentrations in normal-weight and obese humans. N. Engl. J. Med.334, 292–295 (1996).
   PubMed Web of Science ®Google Scholar
• Tong J, Fujimoto WY, Kahn SE et al. Insulin, C-peptide, and leptin concentrations predict increased visceral adiposity at 5- and 10- year follow-ups in nondiabetic Japanese Americans. Diabetes54, 985–990 (2004).
   Google Scholar
• Arita Y, Kihara S, Ouchi N et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun.257, 79–83 (1999).
   PubMed Web of Science ®Google Scholar
• Cigolini M, Targher G, Bergamo Andreis IA, Tonoli M, Agostino G, De Sandre G. Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men. Arterioscler. Thromb. Vasc. Biol.16, 368–374 (1996).
   PubMed Web of Science ®Google Scholar
• Winkler G, Cseh K, Baranyi E et al. Tumor necrosis factor system in insulin resistance in gestational diabetes. Diabetes Res. Clin. Prac.56, 93–99 (2002).
   PubMed Web of Science ®Google Scholar
• Chu N-F, Spiegelmann D, Hotamisligil GS, Rifai N, Stampfer M, Rimm EB. Plasma insulin, leptin, and soluble TNF receptor levels in relation to obesity-related atherogenic anf thrombogenic cardiovascular disease risk factors among men. Atherosclerosis157, 495–503 (2001).
   PubMed Web of Science ®Google Scholar
• Chu NF, Shen MH, Wu DM, Shieh SM. Plasma TNF-R1 and insulin concentrations in relation to leptin levels among normal and overweight children. Clin. Chem.35, 287–92 (2002).
   Google Scholar
• Neely JR, Grotyohann LW. Role of glycolytically derived protons and lactate and damage to the myocardium. Dissociation of adenosine triphosphate levels and recovery function of reperfused ischaemic hearts. Circ. Res.55, 816–824 (1984).
   PubMed Web of Science ®Google Scholar
• Wolff AA, Rotmensch HH, Stanley WC, Ferrari R. Metabolic approaches to the treatment of ischaemic heart disease: the clinician’s perspective. Heart Fail. Rev.7, 187–203 (2002).
   PubMedGoogle Scholar
• Banks WA. The many lives of leptin. Peptides25, 331–338 (2004).
   PubMed Web of Science ®Google Scholar
• Karmazyn M, Purdham DM, Rajapurohitam V, Zeidan A. Leptin as a cardiac hypertrophic factor: a potential target for therapeutics. Trends Cardiovasc. Med.17, 206–211 (2007).
   PubMedGoogle Scholar
• Tartaglia LA, Dembski M, Weng X et al. Identification and expression cloning of a leptin receptor, OB-R. Cell83, 1263–1271 (1995).
   PubMed Web of Science ®Google Scholar
• Keiffer TJ, Habener JF. The adipoinsular axis: effects of leptin on pancreatic β-cells. Am. J. Physiol. Endocrinol. Metab.278, E1–E14 (2000).
   Google Scholar
• Giandomenico G, Dellas C, Czekay RP, Koschnick S, Loskutoff DJ. The leptin receptor system of human platelets. J. Thromb. Haemost.3, 1042–1049 (2005).
   PubMed Web of Science ®Google Scholar
• Quilliot D, Böhme P, Zannad F, Ziegler O. Sympathetic-leptin relationship in obesity: effect of weight loss. Metabolism57, 555–562 (2008).
   PubMed Web of Science ®Google Scholar
• Doehner W, Pflaum CD, Rauchhaus M et al. Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia. Eur. J. Endocrinol.145, 727–735 (2001).
   PubMedGoogle Scholar
• Kolaczynski JW, Nyce MR, Considine RV et al. Acute and chronic effects of insulin on leptin production in humans: studies in vivo and in vitro. Diabetes45(5), 699–701 (1996).
   PubMed Web of Science ®Google Scholar
• Perego L, Pizzocri P, Corradi D et al. Circulating leptin correlates with left ventricular mass in morbid (grade III) obesity before and after weight loss induced by bariatric surgery: a potential role for leptin in mediating human left ventricular hypertrophy. J. Clin. Endocrinol. Metab.90, 4087–4093 (2005).
   PubMed Web of Science ®Google Scholar
• Patel JV, Sosin M, Lim HS et al. Raised leptin concentrations among South Asian patients with chronic heart failure. Int. J. Cardiol.122, 34–40 (2007).
   PubMedGoogle Scholar
• Schulze PC, Kratzsch J, Linke A et al. Elevated serum levels of leptin and soluble leptin receptors in patients with advanced chronic heart failure. Eur. J. Heart Fail.5, 33–40 (2003).
   PubMed Web of Science ®Google Scholar
• Ferrari R, Bachetti T, Confortini R et al. Circulation. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation92, 1479–1486 (1995).
   PubMed Web of Science ®Google Scholar
• Takahashi N, Waelput W, Guisez Y. Leptin is an endogenous protective protein against the toxicity exerted by tumour necrosis factor. J. Exp. Med.189, 207–212 (1999).
   PubMed Web of Science ®Google Scholar
• Szczepaniak LS, Dobbins RL, Metzger GJ et al. Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn. Reson. Med.49, 417–423 (2003).
   PubMed Web of Science ®Google Scholar
• Barouch LA, Gao D, Chen L et al. Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival in murine models of obesity. Circ. Res.98, 119–124 (2006).
   PubMedGoogle Scholar
• McGaffin KR, Sun CK, Rager JJ et al. Leptin signalling reduces the severity of cardiac dysfunction and remodelling after chronic ischaemic injury. Cardiovasc. Res.77, 4–5 (2008).
   PubMedGoogle Scholar
• Weyer C, Funahashi T, Tanaka S et al. Hypoadiponectinemia in obesity and Type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab.86, 1930–1935 (2001).
   PubMed Web of Science ®Google Scholar
• Hara K, Yamauchi T, Imai Y et al. Reduced adiponectin level is associated with severity of coronary artery disease. Int. Heart J.48, 149–153(2007).
   PubMed Web of Science ®Google Scholar
• Patel JV, Lim HS, Hughes EA, Lip GY. Adiponectin and hypertension: a putative link between adipocyte function and atherosclerotic risk? J. Hum. Hypertens.21, 1–4 (2007).
   PubMedGoogle Scholar
• von Eynatten M, Schneider JG, Humpert PM et al. Serum adiponectin levels are an independent predictor of the extent of coronary artery disease in men. J. Am. Coll. Cardiol.47(10), 2124–2126 (2006).
   PubMed Web of Science ®Google Scholar
• Pischon T, Girman CJ, Hotamisligil GS et al. Plasma adiponectin levels and risk of mycardila infarction in men. JAMA291, 1730–1737 (2004).
   PubMed Web of Science ®Google Scholar
• Schulze MB, Shai I, Rimm EB et al. Adiponectin and future coronary heart disease events among men with Type 2 diabetes. Diabetes54, 534–539 (2005).
   PubMed Web of Science ®Google Scholar
• Shibata R, Izumiya Y, Sato K et al. Adiponectin protects against the development of systolic dysfunction following myocardial infarction. J. Mol. Cell Cardiol.42, 1065–1074 (2007).
   PubMed Web of Science ®Google Scholar
• Shibata R, Ouchi N, Ito M et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat. Med.10, 1384–1389 (2004).
   PubMed Web of Science ®Google Scholar
• Liao Y, Takashima S, Maeda N et al. Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism. Cardiovasc. Res.67, 705–713 (2005).
   PubMed Web of Science ®Google Scholar
• Iacobellis G, Petrone A, Leonetti F, Buzzetti R. Left ventricular mass and +276 G/G single nucleotide polymorphism of the adiponectin gene in uncomplicated obesity. Obesity14, 368–372 (2006).
   PubMed Web of Science ®Google Scholar
• Pineiro R, Iglesias MJ, Gallego R et al. Adiponectin is synthesized and secreted by human and murine cardiomyocytes. FEBS Lett.579, 5163–5169 (2005).
   PubMed Web of Science ®Google Scholar
• Wolf G. Adiponectin: a regulator of energy homeostasis. Nutr. Rev.61, 290–292 (2003).
   PubMed Web of Science ®Google Scholar
• Palanivel R, Fang X, Park M . Globular and full-length adiponectin mediate specific changes in glucose and fatty acid uptake and metabolism in cardiomyocytes. Cardiovasc. Res.75, 148–157 (2007).
   PubMedGoogle Scholar
• Lavie CJ, Messerli FH. Cardiovascular adaptation to obesity and hypertension. Chest90, 275–279 (1986).
   PubMed Web of Science ®Google Scholar
• Manson JE, Colditz GA, Stampfer MJ et al. A prospective study of obesity and risk of coronary heart disease in women. N. Engl. J. Med.322, 882–889 (1990)
   PubMed Web of Science ®Google Scholar
• Garavaglia GE, Messerli FH, Nunez BD, Schmieder RE, Grossman E. Myocardial contractility and left ventricular function in obese patients with essential hypertension. Am. J. Cardiol.62, 594–597 (1988).
   PubMed Web of Science ®Google Scholar
• Nakamura T, Funayama H, Kubo N et al. Association of hyperadiponectinemia with severity of ventricular dysfunction in congestive heart failure. Circ. J.70, 1557–1562 (2006).
   PubMedGoogle Scholar
• Kistorp C, Faber J, Galatius S et al. Plasma adiponectin, body mass index and mortality in patients with chronic heart failure. Circulation112, 1756–1762 (2005).
   PubMed Web of Science ®Google Scholar
• Tamura T, Furukawa Y, Taniguchi R et al. Serum adiponectin as an independent predictor of mortality in patients with congestive heart failure. Circ. J.71, 623–630 (2007).
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Osman AF, Milani RV, Mehra MR. Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am. J. Cardiol.91, 891–894 (2003).
   PubMed Web of Science ®Google Scholar
• Horwich TB, Fonarow GC, Hamilton MA et al. The relationship between obesity and mortality in patients with heart failure. J. Am. Coll. Cardiol.38, 789–795 (2001).
   PubMed Web of Science ®Google Scholar
• Mosterd A, Cost B, Hoes AW et al. The prognosis of heart failure in the general population: the Rotterdam Study. Eur. Heart J.22, 1318–1327 (2001).
   PubMed Web of Science ®Google Scholar
• Lim HS, Tayebjee MH, Tan KT, Patel JV, Macfadyen RJ, Lip GYH. Severity differences and relation to coronary artery disease serum adiponectin in coronary heart disease. Heart91, 1605–1606 (2005).
   PubMed Web of Science ®Google Scholar
• Iwashima Y, Katsuya T, Ishikawa K et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension43, 1318–1323 (2003).
   Google Scholar
• Lieb W, Sullivan LM, Harris TB et al. Plasma leptin levels and incidence of heart failure, cardiovascular disease and total mortality in the elderly. Diabetes Care (2008) (In Press).
   Google Scholar